(Q45266929)

11 December 2017

title

CD4+CD161+ T lymphocytes infiltrate Crohn's disease-associated perianal fistulas and are reduced by anti-TNF-α local therapy (English)

1 reference

11 December 2017

0 references

0 references

Francesco Giudici

3

0 references

Laura Maggi

object named as

Laura Maggi

1

0 references

Francesco Annunziato

10

object named as

Francesco Annunziato

1 reference

11 December 2017

Manuela Capone

2

1 reference

11 December 2017

Veronica Santarlasci

4

1 reference

11 December 2017

Valentina Querci

5

1 reference

11 December 2017

Francesco Liotta

6

1 reference

11 December 2017

Ferdinando Ficari

7

1 reference

11 December 2017

Enrico Maggi

8

1 reference

11 December 2017

Francesco Tonelli

9

1 reference

11 December 2017

Lorenzo Cosmi

11

1 reference

11 December 2017

publication date

15 December 2012

1 reference

International Archives of Allergy and Immunology

11 December 2017

published in

1 reference

11 December 2017

volume

161

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

81-86

1 reference

Inflammatory bowel disease

11 December 2017

cites work

1 reference

T cells and cytokines in Crohn's disease

21 January 2018

1 reference

Phenotypic and functional features of human Th17 cells

21 January 2018

1 reference

Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor.

21 January 2018

1 reference

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

21 January 2018

1 reference

Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases

21 January 2018

1 reference

Th17 cytokines and their emerging roles in inflammation and autoimmunity

21 January 2018

1 reference

Th17 cells: a new fate for differentiating helper T cells

21 January 2018

1 reference

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

Rarity of Human T Helper 17 Cells Is due to Retinoic Acid Orphan Receptor-Dependent Mechanisms that Limit Their Expansion

21 January 2018

1 reference

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease

21 January 2018

1 reference

Local injection of Infliximab for the treatment of perianal Crohn's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000343467

1 reference

11 December 2017

1 reference